| HOME >> BIOLOGY >> TECHNOLOGY |
Perry concluded, "The Vermed team has secured the financing for the purchase and is awaiting our shareholder approval. Both organizations are looking forward to completing this transaction and maintaining a long term, mutually beneficial relationship."
About CardioDynamics:
CardioDynamics, the ICG Company, is the innovator and leader of an important medical technology called impedance cardiography. The Company develops, manufactures and markets noninvasive diagnostic and monitoring technologies and medical device electrodes. The Company's ICG Systems are being used by physicians around the world to help battle the number one killer of men and women -- cardiovascular disease. Partners include GE Healthcare and Philips Medical Systems. For additional information, please refer to the company's Web site at http://www.cdic.com.
Forward-Looking (Safe Harbor) Statement:
Except for historical and factual information contained herein, this
press release contains forward-looking statements, including the Company's
ability to obtain the votes necessary to complete the sale of Vermed and
the expected closing of the transaction, the accuracy of which is
necessarily subject to uncertainties and risks including the Company's
primary dependence on the BioZ product line, and various uncertainties
characteristic of early growth companies, as well as other risks detailed
in the Company's filings with the SEC, including its 2006 Form 10-K and
proxy statement filed with the SEC on July 20, 2007. The Company does not
un
'/>"/>
SOURCE CardioDynamics International Corporation![]() Copyright©2007 PR Newswire. |